홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /반응

HCID 86600751, 화합물 → HCID 11215979, 화합물

HRID 2252457
노트
인쇄 미리보기

반응식

HRID 2252457 반응식
C([O:8][C@@H:9]1[C@@H:16]([O:17]CC2C=CC=CC=2)[C@H:15]([O:25]CC2C=CC=CC=2)[C@@H:14]([CH2:33][O:34][C:35]2[CH:36]=[C:37]([C:41]3[CH:46]=[CH:45][C:44]([C@@H:47]4[C@@H:50]([CH2:51][CH2:52][C@@H:53]([C:55]5[CH:60]=[CH:59][C:58]([F:61])=[CH:57][CH:56]=5)[OH:54])[C:49](=[O:62])[N:48]4[C:63]4[CH:68]=[CH:67][C:66]([F:69])=[CH:65][CH:64]=4)=[CH:43][CH:42]=3)[CH:38]=[CH:39][CH:40]=2)[O:13][C@@H:10]1[O:11][CH3:12])C1C=CC=CC=1>C(O)C.[Pd]>[F:69][C:66]1[CH:67]=[CH:68][C:63]([N:48]2[C:49](=[O:62])[C@H:50]([CH2:51][CH2:52][C@@H:53]([C:55]3[CH:56]=[CH:57][C:58]([F:61])=[CH:59][CH:60]=3)[OH:54])[C@H:47]2[C:44]2[CH:43]=[CH:42][C:41]([C:37]3[CH:38]=[CH:39][CH:40]=[C:35]([O:34][CH2:33][C@H:14]4[O:13][C@H:10]([O:11][CH3:12])[C@H:9]([OH:8])[C@@H:16]([OH:17])[C@@H:15]4[OH:25])[CH:36]=3)=[CH:46][CH:45]=2)=[CH:64][CH:65]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

4

반응물 1

HCID 86600751HCID 86600751, 화합물

생성물 1

HCID 11215979HCID 11215979, 화합물수율 36%

시약·촉매·용매 2

HCID 23938Palladium촉매HCID 702Ethanol용매

실험 절차

Methyl 2,3,4-tri-O-benzyl-6-O-(4′-{(2S,3R)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-oxoazetidin-2-yl}biphenyl-3-yl)-α-D-glucopyranoside (70 mg, 0.08 mmol) was dissolved in absolute ethanol (3 mL). 10% Pd/C (wet, 14% w/w) was added and the vessel sealed. The solution was degassed by evacuation and flushing with hydrogen gas at balloon pressure. The reaction was monitored by TLC (1:1 hexane-ethyl acetate). Upon completion, the catalyst was filtered by passing through a plug of Celite® and washing with additional ethanol. The filtrate was concentrated in vacuo and purified by preparative HPLC (Polaris C18-A 10 μ 250×21.2 mm column, 30% to 95% acetonitrile-0.1% trifluoroacetic acid in water) affording methyl 6-O-(4′-{(2S,3R)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-oxoazetidin-2-yl}biphenyl-3-yl)-α-D-glucopyranoside (18.1 mg, 36% yield); 1H NMR (300 MHz, CDCl3/1% CD3OD) δ 7.58 (d, J=8.4 Hz, 2H), 7.38-7.23 (m, 7H), 7.17-7.14 (m, 2H), 7.04-6.92 (m, 5H), 4.80 (d, J=3.9 Hz, 1H), 4.70 (d, J=2.4 Hz, 1H), 4.67 (t, J=5.7 Hz, 1H), 4.37-4.33 (m, 1H), 4.26-4.21 (m, 1H), 3.92-3.87 (m, 1H), 3.74-3.45 (m, 3H), 3.42 (s, 3H), 3.18-3.10 (m, 1H), 2.01-1.88 (m, 4H) ppm; MS [M−OH]+ 644.0.

후처리

  1. customthe vessel sealed
  2. customThe solution was degassed by evacuation
  3. customflushing with hydrogen gas at balloon pressure
  4. filtrationUpon completion, the catalyst was filtered
  5. washwashing with additional ethanol
  6. concentrationThe filtrate was concentrated in vacuo
  7. custompurified by preparative HPLC (Polaris C18-A 10 μ 250×21.2 mm column, 30% to 95% acetonitrile-0.1% trifluoroacetic acid in water)

출처 및 근거

ORD 기록
ord-ff1b152de3d6417691fccfeb844639d0
출처 데이터셋
uspto-grants-2008_01
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US07320972B2

반응 노트

불러오는 중…

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트